Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Free Cash Flow Growth (3y) (2013 - 2026)

Analysis

Emergent BioSolutions (EBS) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 33.62%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -20.26%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 17.80%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 17.73%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 28.91%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 23.79%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 56.97%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 45.09%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 34.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.36%
Mar 31, 2026 43.35%
Dec 31, 2025 -7.35%
Sep 30, 2025 71.77%
Jun 30, 2025 60.96%
Mar 31, 2025 40.28%
Dec 31, 2024 -31.79%
Sep 30, 2024 80.10%
Jun 30, 2024 34.69%
Mar 31, 2024 -12.90%
Dec 31, 2023 -53.74%
Sep 30, 2023 -7.30%
Jun 30, 2023 -49.89%
Mar 31, 2023 -99.38%
Dec 31, 2022 2.57%
Sep 30, 2022 -139.70%
Jun 30, 2022 1.49%
Mar 31, 2022 -41.50%
Dec 31, 2021 52.02%
Sep 30, 2021 -31.24%
API Access

Emergent BioSolutions Free Cash Flow Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow-growth-3y&ticker=EBS&period=max&api_key=YOUR_API_KEY